The epidemiology of drug-induced systemic lupus erythematosus.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects*; D006973:Hypertension / Q000188:drug therapy; D007538:Isoniazid / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009519:New York City; D010672:Phenytoin / Q000009:adverse effects*; D011342:Procainamide / Q000009:adverse effects*
D006830:Hydralazine; D010672:Phenytoin; D011342:Procainamide; D007538:Isoniazid